Skip to main content
PHARMANIAGA BERHAD logo

PHARMANIAGA BERHAD — Investor Relations & Filings

ISIN · MYL7081OO002 BURSA Manufacturing
Open in API
Filings indexed 49 across all filing types
Latest filing 2026-05-20 Share Issue/Capital Cha…
Country MY Malaysia
Listing BURSA

About PHARMANIAGA BERHAD

https://pharmaniaga.com/

Pharmaniaga Berhad is an integrated pharmaceutical group with core activities spanning research and development, manufacturing of generic pharmaceuticals, marketing, sales, warehousing, logistics, and distribution. The company offers a diverse portfolio including pharmaceutical products, diagnostic products, and food supplements, alongside operating community pharmacies. It emphasizes an integrated approach across the pharmaceutical value chain, driven by a commitment to sustainability and ethical business practices.

Recent filings

Filing Released Lang Actions
PHARMA - Notice of Book Closure
Share Issue/Capital Change Classification · 90% confidence The document is a formal announcement of a share consolidation (capital reorganization) with details on ex-date, book closure, entitlement date, and adjusted share counts. This constitutes a change in the company’s capital structure (consolidation of shares). According to the classification definitions, announcements regarding share consolidation, stock splits, and other capital changes fall under “Share Issue/Capital Change” (SHA).
2026-05-20 English
Share Consolidation
Share Issue/Capital Change Classification · 95% confidence The document is a corporate action announcement detailing a share consolidation (reverse stock split) with ex-date, entitlement date, listing date, and registrar information. This falls squarely under share issue/capital change announcements (stock splits, consolidations). It is not a full financial report but a capital change notice. Therefore, it matches the Share Issue/Capital Change category.
2026-05-19 English
General Meetings: Outcome of Meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 97% confidence The document contains detailed voting results by poll for each resolution at Pharmaniaga Berhad’s 28th Annual General Meeting held on May 19, 2026. It is not a presentation or the full annual report, but an official declaration of shareholder vote counts. This matches the definition for Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-05-18 English
General Meetings: Outcome of Meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 92% confidence The document provides detailed voting results by poll from the 2026 Extraordinary General Meeting (EGM), including vote counts for, against, abstentions, and spoilt votes. This is a formal declaration of voting results at a shareholder meeting, matching the Definition of Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-05-18 English
PHARMA - Notice of Book Closure
Notice of Dividend Amount Classification · 98% confidence The document is a notice announcing details of an interim dividend (ex-dividend date, book closure date, payable date) rather than a detailed report or presentation. It fits the definition of a Notice of Dividend Amount (DIV).
2026-05-18 English
Interim Dividend
Notice of Dividend Amount Classification · 85% confidence The document is a corporate announcement specifying an interim dividend: ex-date, entitlement date, payment date, dividend rate in MYR, and book closure details. This matches a Notice of Dividend Amount rather than a full financial report or other filings.
2026-05-17 English

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.